ngsuro | 1025
NGS Bladder Carcinoma
Keywords:
FGFR1
FGFR2
FGFR3
FGFR4
Next Generation Sequencing
Urinary Bladder
Urinary bladder Carcinoma
Urothelial Carcinoma
Urothelium
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Variants Hotspot: FGFR1, FGFR2, FGFR3, FGFR4; Whole Sequencing: TP53; Fusions: FGFR1, FGFR2, FGFR3, FGFR4 as well as pathogen variants for Oncomine Comprehensive Assays v3 DNA and RNA. To order this analysis, please contact the Customer Service Center: contact@viollier.ch or 0848 121 121.This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG shall ensure the patient is informed accordingly (see www.viollier.ch/en/SGMG_consent). Tarification: according to Tarmed. |
||
| Duration | 5 days | ||
| Frequency | 2 x per week | ||
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 0.00
|
|---|---|
| Rate |
Rate
0.00 TP
|